Molecular medicine symposium draws internationally renowned experts
Gene targeting therapies continue to expand the horizon for diagnosing and treating a range of inherited and acquired diseases, with...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
The PNAT laboratory is led by Associate Professor Rakesh Veedu.
Our research in this area is categorised into three main thematic areas:
Over the last five years, the Precision Nucleic Acid Therapeutics Research Group has developed and identified potential gene-targeting synthetic drug candidates towards the treatment of diabetic retinopathy & macular degeneration, Type-2 diabetes, Psoriasis, and solid cancers including liver cancer. The group are developing novel oligonucleotide drug chemistry, design and unique delivery cargos towards targeted therapy of the above conditions.
Our future focus is towards obtaining translational milestones including preclinical evaluations and commencing clinical trials.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.